Former Advanz chief faces disqualification action, UK’s CMA says
MLex Summary: John Beighton, the former CEO of Advanz Pharma, is facing potential High Court proceedings which could lead to his disqualification as a company director, the UK Competition and Markets...To view the full article, register now.
Already a subscriber? Click here to view full article